MedPath

Evaluation of remission induction with hyper CVAD chemotherapy in ALL patients in seyedoshohada hospital in Isfehan in 1388 and 1389.

Phase 2
Conditions
Acute lymphoblastic leukaemia
Acute lymphoblastic leukaemia.
Registration Number
IRCT138806142417N1
Lead Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

diagnosis of ALL
Exclusion criteria: age between 14-50, serum bilirubin less than 4mg/dl, cardiac output less than 50%, Pregnancy, performance status based on Karnophski scale less than 60

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete remission. Timepoint: At the end of treatment. Method of measurement: bone marrow examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath